Rao Prasanna Kumar
Department of Oral Medicine and Radiology, Yenepoya Dental College, Yenepoya University, Mangalore, India.
J Cancer Res Ther. 2010 Oct-Dec;6(4):508-10. doi: 10.4103/0973-1482.77087.
Oral submucous fibrosis (OSF) is a chronic irreversible condition of the oral mucosa with proven malignant potential. However, till date, there has been a dearth of effective management strategies. This study used alpha lipoic acid, an antioxidant, in oral form to determine if it could be useful in managing OSF patients.
A case-control study was conducted on 18 patients of OSF (9 cases and 9 controls). The case group was treated using alpha lipoic acid in addition to the intralesional steroid and hyaluronidase injections used in the control group.
The cases in the alpha lipoic acid group exhibited better relief of symptoms such as burning sensation of the mucosa and mouth opening, as compared to the controls. The use of alpha lipoic acid along with intralesional steroids and hyaluronidase caused reversal of higher clinical stages to lower ones.
The use of an antioxidant, alpha lipoic acid, along with conventional therapy of intralesional steroid injections definitely seems to have a beneficial impact in the management of OSF.
口腔黏膜下纤维化(OSF)是一种口腔黏膜的慢性不可逆病症,已证实具有恶变潜能。然而,迄今为止,缺乏有效的治疗策略。本研究使用口服形式的抗氧化剂α-硫辛酸,以确定其是否有助于治疗OSF患者。
对18例OSF患者(9例病例和9例对照)进行了病例对照研究。病例组除使用对照组中采用的病灶内注射类固醇和透明质酸酶外,还使用α-硫辛酸进行治疗。
与对照组相比,α-硫辛酸组的病例在缓解黏膜烧灼感和张口等症状方面表现更佳。α-硫辛酸与病灶内类固醇和透明质酸酶联合使用可使较高临床分期逆转为较低分期。
抗氧化剂α-硫辛酸与病灶内注射类固醇的传统疗法联合使用,在OSF的治疗中似乎确实具有有益影响。